Business

Response to Statement re Possible Offer

Response to Statement re Possible Offer.

articleAdvanced Medical Solutions Group PlcMarch 27, 20255/company/advanced-medical-solutions-group-plc/news/response-to-statement-re-possible-offer
Response to Statement re Possible Offer

About this update from Advanced Medical Solutions Group Plc

[{"type":"text","content":"\n\nFOR IMMEDIATE RELEASE\n \nNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION\n \nTHIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE \"CODE\") AND DOES NOT CONSTITUTE AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE CODE. THERE CAN BE NO CERTAINTY THAT ANY OFFER WILL BE MADE, NOR AS TO THE TERMS ON WHICH ANY OFFER MAY BE MADE\n \nTHIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION\n \n27 March 2025\nAdvanced Medical Solutions Group plc\n(\"AMS\" or the \"Company\")\nResponse to Statement by Montagu Private Equity LLP (\"Montagu\")\nThe Board of AMS notes the announcement made earlier today by Montagu regarding a possible offer for AMS. The Board of AMS is not in receipt of a proposal from Montagu. There can be no certainty that a firm offer will be made for AMS, nor as to the terms on which a firm offer might be made.\nIn accordance with Rule 2.6(a) of the Code, Montagu is required, by no later than 5.00 p.m. (London time) on 24 April 2025, being 28 days after today's date, to either announce a firm intention to make an offer for AMS in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Takeover Panel in accordance with Rule 2.6(c) of the Code.\n \nAs a consequence of Montagu's announcement, the Company is now in an \"offer period\" as defined in the Code and the attention of the Company's shareholders is drawn to the dealing disclosure requirements of Rule 8 of the Code, which are summarised below.\n \nA further announcement will be made as and when appropriate.\n \n\n\n\n\nAdvanced Medical Solutions Group plc\n\n\n+44 (0) 1606 545508\n\n\n\n\nChris Meredith, Chief Executive Officer\nEddie Johnson, Chief Financial Officer\nMichael King, Head of Investor Relations\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nEvercore Partners International LLP\n(Financial Adviser)\n\n\n+44 (0) 207 653 6000\n\n\n\n\nSimon Elliott\nJulian Oakley\nTorera Oyewo\nHarrison George\n \n\n\n\n\n\n\n\nInvestec Bank PLC\n(Financ...

More updates from Advanced Medical Solutions Group Plc